Alterations of expression and imprinting status of Insulin-like Growth Factor 2 and H19 in diabetes mellitus patients' placenta

Yu-mei WEI,Jing ZHANG,Hui-xia YANG
DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2012.07.008
2012-01-01
Abstract:Objective To investigate the alterations of expression and imprinting status of insulin growth factor 2 (IGF2) and H19 gene in diabetes mellitus patients' placenta.Methods 66 pregnant women delivered between February to September 2009 were inrolled,33 cases with diabetes mellitus ( Patient group,GDM 23 cases ( NDDG ( National Diabetes Data Group) criteria),DM 10 cases) and 31 cases with normal glucose tolerance( Control group).RNA and DNA were extracted from the placenta of all objects.Real-Time PCR was performed to compare the expression of IGF2 and H19 gene in different groups,and RELP was used to identify the alternations of imprinting status.Statistical analyses were done by SPSS software (V10.0,SPSS Inc,USA).P values < 0.05 were considered statistically significant.Results ( 1 ) Compared with the control group,the expression of IGF2 gene was significantly higher ( 2.4 ± 1.2 vs 1.9 ±0.8,t =-2.2,P <0.05)in the patients groups.The expression of H19 gene was higher (7.2 ±3.6 vs 6.1 ±2.7,t =- 1.5,P >0.05) in the patient group compared with that of control group,whereas there were no significant difference between them.(2) The genetic heterogeneity of IGF2 gene Apal locus was 60.9% (39/64),and the geneticheterogeneity of H19 gene Rsal locus was 34.4% (22/64).(3) The expression of IGF2 gene Apal locus and H19 gene Rsal locus was no loss of imprinting in the patient group and the control group.Conclusion ( 1 ) The expression of IGF2 gene is increased in the placenta of diabetes mellitus patients. (2) The expression of IGF2 and H19 gene in the placenta of gestational hyperglycemia patients has no loss of imprinting.
What problem does this paper attempt to address?